Rhenman & Partners Asset Management’s Health Catalyst HCAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-300,000	Closed	-$2.78M	–	87
2023 Q4	$2.78M	Sell	300,000 -20,000	-6%	-$163K	0.28%	68
2023 Q3	$3.24M	Hold	320,000	–	–	0.35%	63
2023 Q2	$4M	Sell	320,000 -20,000	-6%	-$238K	0.42%	60
2023 Q1	$3.87M	Buy	340,000 +160,000	+89%	+$2.04M	0.42%	63
2022 Q4	$1.91M	Hold	180,000	–	–	0.2%	83
2022 Q3	$1.59M	Hold	180,000	–	–	0.17%	86
2022 Q2	$2.61M	Hold	180,000	–	–	0.3%	72
2022 Q1	$4.7M	Sell	180,000 -60,000	-25%	-$1.7M	0.46%	63
2021 Q4	$9.73M	Hold	240,000	–	–	0.65%	54
2021 Q3	$12M	Hold	240,000	–	–	0.84%	46
2021 Q2	$13.3M	Buy	240,000 +125,000	+109%	+$6.66M	0.9%	47
2021 Q1	$5.38M	Buy	+115,000	New	+$5.57M	0.38%	72